High Dose Epirubicin is Effective in Measurable Metastatic Prostate Cancer: a Phase II Study of the EORTC Genitourinary Group

Author： EORTC Genitourinary Cancer Research Group   Brausi M.   Jones W.G.   Fossa S.D.   de Mulder P.H.M.   Droz J.-P.   Lentz M.-A.   van Glabbeke M.   Pawinski A.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.10, 1995-09, pp. : 1622-1626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Weekly 4'-Epidoxorubicin in Patients with Metastatic Adenocarcinoma of the Cervix: an EORTC Gynaecological Cancer Cooperative Group Study

By van der Burg M.E.L.   Bolis G.   Bakker P.J.M.   Curran D.   Sahmoud T.   Vermorken J.B.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1513-1515

Elsevier

Access to resources Recommend Favorite

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial - an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study

By Pectasides D.   Visvikis A.   Aspropotamitis A.   Halikia A.   Karvounis N.   Dimitriadis M.   Athanassiou A.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 74-79

Elsevier

Access to resources Recommend Favorite

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

By Lalisang R.   Erdkamp F.   Rodenburg C.   Knibbeler-van Rossum C.   Nortier J.   Bochove A.   Slee P.   Voest E.   Wils J.   Wals J.   Loosveld O.   Smals A.   Blijham G.   Tjan-Heijnen V.   Schouten H.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 437-445

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group - is it feasible?

By Nielsen O.S.   Judson I.   van Hoesel Q.   le Cesne A.   Keizer H.J.   Blay J.Y.   van Oosterom A.   Radford J.A.   Svancarova L.   Krzemienlecki K.   Hermans C.   van Glabbeke M.   Oosterhuis J.W.   Verweij J.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 61-67

Elsevier

Access to resources Recommend Favorite